Physician profile
Yvette Ramirez
NPI 1730533829
$2,250.85
in general payments reported to CMS, 2019-2025
15 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $52.80 · 2023: $580 · 2024: $1,134 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514 · Travel and Lodging: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.00 |
| Travel and Lodging | $470.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $961.45 | 2023-2024 | Axonics |
| Coloplast Corp | $485.01 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $210.01 | 2022-2023 | Xiaflex, Aveed |
| Convatec INC. | $146.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $135.00 | 2023 | Fasenra |
| Myriad Genetic Laboratories, INC. | $62.35 | 2024 | Prolaris |
| Astellas Pharma US INC | $50.93 | 2021 | |
| Laborie Medical Technologies Corp. | $31.11 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $29.86 | 2025 | Xiaflex |
| Urovant Sciences INC | $29.79 | 2022 | |
| Urogen Pharma, INC. | $28.34 | 2024 | |
| 180 Medical, INC. | $26.91 | 2023 | Gentlecath |
| Olympus America INC. | $23.59 | 2023 | Itind System |
| Boston Scientific Corporation | $16.02 | 2021 | |
| Abc Home Medical Supply, INC. | $13.64 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.